September 2012 Issue Table Of Contents

From The Editor

• A Pricey Path To Drug Discovery

Ask The Board

• Ask The Board September 2012

Companies To Watch

• PsiOxus’ Brave Agenda To Destroy Cancer Cells

Outsourcing Insights

• A Diversified Portfolio Of CROs Might Improve Results

Big Data Points

• Adoption Of Single-Use Applications Are Increasing In Biopharm Manufacturing

Feature

• Rediscovering Generics - Sandoz Vows To Serve Patients First
• Sanofi: Betting On North American Pharmaceutical & Biopharm Industries
• Can Rapid Mobile Diagnostics Speed Up Clinical Trials And Regulatory Reviews?

Inside The Industry

• Comparing China’s And India’s Pharmaceutical Manufacturing
• Prefilled Syringes: The Next “Big Thing”
• Sunshine Act Compliance: Are You Prepared?
• 5 Reasons For Using Integrated EDC/EHR Platforms

Industry Leader

• How To Successfully Navigate The Orphan Designation Process
• A Forgotten Majority: Patient Diversity In Clinical Trials
• The Need For Actionable Data In Cold Chain Logistics